Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma

Chun, YS; Javle, M

Javle, M (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.

CANCER CONTROL, 2017; 24 (3):

Abstract

Intrahepatic cholangiocarcinoma represents the second most common primary liver cancer and is increasing in incidence. Most patients are diagnosed at ......

Full Text Link